Harnessing massively parallel DNA sequencing for the personalization of cancer management

Personalized Medicine
Michael F Berger

Abstract

In order to properly diagnose and classify tumors and select the most appropriate therapies for patients, one must accurately and efficiently identify oncogenic mutations in key cancer-associated genes. Massively parallel DNA sequencing technology has the potential to dramatically enhance the field of molecular diagnostics. For increasingly lower costs, one can interrogate all clinically relevant genes for mutations, copy number alterations and structural rearrangements, with high detection sensitivity in heterogeneous tissue. Advances in exon capture, molecular barcoding and profiling of formalin-fixed paraffin-embedded specimens have further established the clinical potential of massively parallel sequencing. This article discusses promising strategies for DNA sequencing as a clinical tool and also the challenges in its implementation in the clinical arena.

References

Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Feb 22, 2001·Science·J C VenterX Zhu
Mar 10, 2001·Nature·E S LanderUNKNOWN International Human Genome Sequencing Consortium
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Aug 16, 2002·The New England Journal of Medicine·George D DemetriHeikki Joensuu
Aug 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·William PaoHarold Varmus
Oct 22, 2004·Nature·UNKNOWN International Human Genome Sequencing Consortium
Apr 19, 2006·Cancer Research·Astrid LièvrePierre Laurent-Puig
Feb 13, 2007·Nature Genetics·Roman K ThomasLevi A Garraway
Apr 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F Stephen HodiDavid E Fisher
May 31, 2008·Pigment Cell & Melanoma Research·Jose LutzkyBoris C Bastian
Jul 4, 2008·The New England Journal of Medicine·Shyamala MaheswaranDaniel A Haber
Aug 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Peter J CampbellMichael R Stratton
Sep 17, 2008·Nature Methods·David W CraigMatthew J Huentelman
Oct 11, 2008·Nature Biotechnology·Jay Shendure, Hanlee Ji
Nov 7, 2008·Nature·Timothy J LeyRichard K Wilson
Nov 19, 2008·Nature Reviews. Genetics·Zhong WangMichael Snyder
Apr 11, 2009·Nature·Michael R StrattonP Andrew Futreal
Aug 7, 2009·The New England Journal of Medicine·Elaine R MardisTimothy J Ley
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka
Aug 27, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·William PaoThomas J Lynch
Sep 9, 2009·Nature Reviews. Genetics·Peter J Park
Nov 20, 2009·PloS One·Laura E MacConaillLevi A Garraway
Dec 17, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Scott KopetzJohn V Heymach
Dec 18, 2009·Nature·Erin D PleasanceMichael R Stratton
Dec 18, 2009·Nature·Erin D PleasancePeter J Campbell
Jan 30, 2010·Nature Methods·Lira MamanovaDaniel J Turner
Apr 8, 2010·Science Translational Medicine·Rebecca J LearyVictor E Velculescu
Apr 16, 2010·Nature·UNKNOWN International Cancer Genome ConsortiumHuanming Yang
Aug 11, 2010·Genome Biology·Steven Jm JonesMarco A Marra
Sep 18, 2010·Nature Reviews. Genetics·Matthew MeyersonGad Getz
Sep 30, 2010·Proceedings of the National Academy of Sciences of the United States of America·Ivana BozicMartin A Nowak
Oct 19, 2010·Nucleic Acids Research·Simon A ForbesP Andrew Futreal
Nov 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark G KrisNicholas J Petrelli
Dec 3, 2010·The Journal of Pathology·Barry S Taylor, Marc Ladanyi
Feb 11, 2011·Nature·Michael F BergerLevi A Garraway
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Mar 9, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nikhil WagleLevi A Garraway
Mar 15, 2011·Nature·Nicholas NavinMichael Wigler

❮ Previous
Next ❯

Citations

Sep 24, 2019·Nutrition and Cancer·Afshin KaramiAhmad Gharehbaghian

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.